Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate whether low-molecular-weight heparine (Enoxaparine, Dalteparine, Nadroparine, Tinzaparine) is superior to vitamin K antagonists (VKA) in the long-term treatment of symptomatic venous thromboembolism in cancer patients who have completed 6 to 12 months of anticoagulant treatment
Critère d'inclusion
- Deep venous thrombosis or pulmonary embolism in patients with cancer